YK-2168, CAS [[2571068-74-9]]

Produktübersicht

• Artikelname: YK-2168, CAS [[2571068-74-9]]
• Artikelnummer: MCE-HY-162919
• Hersteller Artikelnummer: HY-162919
• Alternativnummer: MCE-HY-162919-25MG,MCE-HY-162919-10MG,MCE-HY-162919-10MMX1ML,MCE-HY-162919-5MG,MCE-HY-162919-50MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

YK-2168 is a potent and selective CDK9 inhibitor with an IC50 of 5.9 nM. YK-2168 inhibits phosphorylation of the CDK9 substrate pS2-RNA Pol II C-terminal domain. YK-2168 induces apoptosis in tumor cells, suppresses expression of CDK9-regulated genes including MYC and Mcl1, and inhibits tumor growth in CDX mice models. YK-2168 can be used for the research of cancer, such as leukemia[1].

Produkteigenschaften

• Molekulargewicht: 315.80
• Reinheit: 98.05
• CAS Nummer: [2571068-74-9]
• Formel: C16H18ClN5
• Target-Kategorie: Apoptosis,CDK,c-Myc

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound